Your session is about to expire
← Back to Search
Virtual vs Center-Based Cardiac Rehab for Cardiovascular Disease (VWCR Trial)
N/A
Waitlist Available
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months and 6 months post-randomization
Awards & highlights
VWCR Trial Summary
This trial will test an online CR program to see if it's as effective & easier to stick to than traditional CR programs.
Who is the study for?
This trial is for adults over 18 who need cardiac rehab based on specific health conditions like recent heart attacks, surgeries, or stable heart issues. They must be able to use the internet and have an email address. It's not for high-risk patients with severe heart problems, those needing constant support, non-English speakers, or pregnant women.Check my eligibility
What is being tested?
The study compares a new Virtual World-Based Cardiac Rehabilitation (VWCR) program called 'Destination Cardiac Rehab' with traditional center-based rehabilitation to see if it's just as effective and whether people stick with it.See study design
What are the potential side effects?
Since this trial involves exercise and education programs rather than medication, side effects are minimal but may include typical risks associated with physical activity such as muscle soreness or strain.
VWCR Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3 months and 6 months post-randomization
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months and 6 months post-randomization
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Life's Essential 8 component: Blood Glucose
Life's Essential 8 component: Blood Pressure
Life's Essential 8 component: Body Mass Index (BMI)
+7 moreSecondary outcome measures
Diet Self-efficacy
Diet Self-regulation
Diet Social Support
+7 moreVWCR Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Virtual World-Based Cardiac Rehab (VWCR)Experimental Treatment1 Intervention
Telehealth delivery of cardiac rehabilitation via Second Life virtual world platform. 12-week, home-based program.
Group II: Center-Based Cardiac Rehab (CBCR)Active Control1 Intervention
Standard of care for participants' center-based cardiac rehabilitation program. Traditional 12-week, in-person program.
Find a Location
Who is running the clinical trial?
Mayo ClinicLead Sponsor
3,239 Previous Clinical Trials
3,771,449 Total Patients Enrolled
2 Trials studying Telemedicine
229 Patients Enrolled for Telemedicine
Johns Hopkins UniversityOTHER
2,274 Previous Clinical Trials
14,840,367 Total Patients Enrolled
4 Trials studying Telemedicine
379 Patients Enrolled for Telemedicine
University of California, IrvineOTHER
545 Previous Clinical Trials
1,922,961 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have chest pain that isn't managed by medication.My heart cannot pump blood effectively anymore.I have an active email address.I am on constant medication to strengthen my heart's contractions.I am 18 years old or older.I do not speak English.I have heart valve problems causing symptoms.I qualify for cardiac rehab due to a recent heart issue or surgery.
Research Study Groups:
This trial has the following groups:- Group 1: Center-Based Cardiac Rehab (CBCR)
- Group 2: Virtual World-Based Cardiac Rehab (VWCR)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger